John McAnulty is a Cardiology physician affiliated with Legacy Health. OpenAlex indexes 157 publications with 43,834 citations (h-index 42). By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1040 NW 22nd Ave, Suite 660
Portland, OR 97210
Telephone
503-413-7162Registry record last updated 10 Jun 2019.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HEARTFLOW, INC.Program year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20231 payment
- Medtronic, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.8%Beta blocker23.9%Metoprolol Succinate60%Metoprolol Tartrate10%Atenolol9%Sotalol7%Propranolol Hcl6%Carvedilol4%Propranolol Hcl Er3%Part D<11 patientsAntiarrhythmic15.9%Flecainide Acetate68%Amiodarone Hcl19%Propafenone Hcl Er6%Dofetilide4%Propafenone Hcl3%Part D<11 patients+ 10 more classes in this area
Blood & clotting
21.2%Factor Xa inhibitor19.9%Xarelto54%Eliquis46%Part D≥76 patientsVitamin K antagonist0.8%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.1%SGLT2 inhibitor4.7%Jardiance86%Farxiga14%Part D<11 patientsPotassium supplement1.4%Potassium Chloride100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1985–2004 per NIH RePORTER. The latest:
- Antiarrhythmic Effects of n-3 Fatty Acids
Oregon Health and Science University
FY2004$30,556M01RR000334 - ANTIARRHYTHMIC EFFECTS OF N-3 FATTY ACIDS
Oregon Health and Science University
FY2002$646,961R01HL061682 - ANTIARRHYTHMIC EFFECTS OF N-3 FATTY ACIDS
Oregon Health and Science University
FY2001$528,714R01HL061682
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Arrhythmias After Heart Transplantation: Mechanisms and Management
Journal of the American Heart Association
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Mansberger, MD, MPH
Legacy Health
Claude Burgoyne, MD
Legacy Health
Brandon Lujan, MD
Legacy Health
William Shults, MD
Legacy Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”